ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995